Article Text

Download PDFPDF
Letter to the Editor
Five years of self-administered hyaluronidase facilitated subcutaneous immunoglobulin (fSCIg) home therapy in a patient with primary immunodeficiency

Statistics from Altmetric.com

Footnotes

  • Contributors All authors have contributed to the writing and review of the report and meet the criteria for authorship.

  • Funding SJ is supported by a NISCHR Fellowship.

  • Competing interests SJ has received support from Baxter, CSL Behring, Shire, Octapharma, SOBI and Biotest for conferences, consulting and research. He is Immunology Editor of JCP.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.